NRx Pharmaceuticals Introduces NRX-101, A Potential Game-Changer in Antibiotic Therapy
RADNOR, PA — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) recently unveiled promising new data on NRX-101, a drug showing no measurable impact on gut or vaginal flora in rodent models, contrasting …
NRx Pharmaceuticals Introduces NRX-101, A Potential Game-Changer in Antibiotic Therapy Read More